Clinical trial
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With…
NCT00246922 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00246922 |
|---|---|
| Title | Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07) |
| Official title | A Long-term Study of APTA-2217 in Adult Patients With Bronchial Asthma |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | Roflumilast |
| Enrollment | 150 |
| Start date | Dec 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Nov 1, 2005 |
| Last update posted | Dec 2, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: